Find the Money Before the Patent Dies: How to Identify Out-Licensing Targets Near Drug Patent Expiry — and Capture Value That Most Companies Leave on the Table
Most companies treat out-licensing like a last-minute scramble.
They wait until a patent is already wobbling—then scramble to “find partners,” negotiate terms, and hope the market is still interested. By then, the value has already leaked out: competit…
